DE69228069D1 - 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxochinolin Derivate, als antihypercholesterolemische und antiatherosklerotische Mittel - Google Patents
4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxochinolin Derivate, als antihypercholesterolemische und antiatherosklerotische MittelInfo
- Publication number
- DE69228069D1 DE69228069D1 DE69228069T DE69228069T DE69228069D1 DE 69228069 D1 DE69228069 D1 DE 69228069D1 DE 69228069 T DE69228069 T DE 69228069T DE 69228069 T DE69228069 T DE 69228069T DE 69228069 D1 DE69228069 D1 DE 69228069D1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- nitrogen
- group
- compounds
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82463992A | 1992-01-23 | 1992-01-23 | |
PCT/US1992/010886 WO1993015058A1 (en) | 1992-01-23 | 1992-12-21 | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69228069D1 true DE69228069D1 (de) | 1999-02-11 |
DE69228069T2 DE69228069T2 (de) | 1999-05-20 |
Family
ID=25241935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69228069T Expired - Fee Related DE69228069T2 (de) | 1992-01-23 | 1992-12-21 | 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxochinolin Derivate, als antihypercholesterolemische und antiatherosklerotische Mittel |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0623112B1 (de) |
JP (1) | JP2668163B2 (de) |
KR (1) | KR950700284A (de) |
AT (1) | ATE175196T1 (de) |
AU (1) | AU3323393A (de) |
CA (1) | CA2128093C (de) |
DE (1) | DE69228069T2 (de) |
DK (1) | DK0623112T3 (de) |
ES (1) | ES2125325T3 (de) |
FI (2) | FI930264A (de) |
HU (1) | HUT63625A (de) |
IL (1) | IL104420A0 (de) |
MX (1) | MX9300361A (de) |
NO (1) | NO942757D0 (de) |
WO (1) | WO1993015058A1 (de) |
ZA (1) | ZA93482B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
EP1086948A4 (de) * | 1998-02-25 | 2004-03-10 | Sumitomo Pharma | Pyridonderivate und verfahren zu ihrer herstellung |
AP2002002612A0 (en) | 2000-02-02 | 2002-09-30 | Warner Lambert Co | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
CA2572442A1 (fr) * | 2004-07-30 | 2006-03-09 | Palumed S.A. | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
FR2874922A1 (fr) * | 2004-07-30 | 2006-03-10 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
MX22406A (es) * | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
TW205037B (de) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
US5278186A (en) * | 1990-02-10 | 1994-01-11 | Takeda Chemical Industries, Ltd. | Chromene derivatives, their production and use |
EP0590094A1 (de) * | 1991-04-26 | 1994-04-06 | Pfizer Inc. | 4-aryl-3-heteroarylureidochinoline derivate |
-
1992
- 1992-12-21 ES ES93901257T patent/ES2125325T3/es not_active Expired - Lifetime
- 1992-12-21 DK DK93901257T patent/DK0623112T3/da active
- 1992-12-21 CA CA002128093A patent/CA2128093C/en not_active Expired - Fee Related
- 1992-12-21 DE DE69228069T patent/DE69228069T2/de not_active Expired - Fee Related
- 1992-12-21 JP JP5513207A patent/JP2668163B2/ja not_active Expired - Fee Related
- 1992-12-21 AT AT93901257T patent/ATE175196T1/de not_active IP Right Cessation
- 1992-12-21 WO PCT/US1992/010886 patent/WO1993015058A1/en active IP Right Grant
- 1992-12-21 AU AU33233/93A patent/AU3323393A/en not_active Abandoned
- 1992-12-21 EP EP93901257A patent/EP0623112B1/de not_active Expired - Lifetime
-
1993
- 1993-01-18 IL IL104420A patent/IL104420A0/xx unknown
- 1993-01-22 HU HU9300197A patent/HUT63625A/hu unknown
- 1993-01-22 ZA ZA93482A patent/ZA93482B/xx unknown
- 1993-01-22 MX MX9300361A patent/MX9300361A/es unknown
- 1993-01-22 FI FI930264A patent/FI930264A/fi unknown
-
1994
- 1994-07-22 NO NO942757A patent/NO942757D0/no unknown
- 1994-07-22 KR KR1019940702519A patent/KR950700284A/ko not_active Application Discontinuation
-
2001
- 2001-01-12 FI FI20010074A patent/FI20010074A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CA2128093C (en) | 1998-02-03 |
FI930264A (fi) | 1993-07-24 |
ES2125325T3 (es) | 1999-03-01 |
FI20010074A (fi) | 2001-01-12 |
KR950700284A (ko) | 1995-01-16 |
AU3323393A (en) | 1993-09-01 |
DK0623112T3 (da) | 1999-08-30 |
EP0623112A1 (de) | 1994-11-09 |
JP2668163B2 (ja) | 1997-10-27 |
HUT63625A (en) | 1993-09-28 |
FI930264A0 (fi) | 1993-01-22 |
ZA93482B (en) | 1994-07-22 |
NO942757L (no) | 1994-07-22 |
IL104420A0 (en) | 1993-05-13 |
EP0623112B1 (de) | 1998-12-30 |
JPH07503712A (ja) | 1995-04-20 |
HU9300197D0 (en) | 1993-04-28 |
MX9300361A (es) | 1994-06-30 |
CA2128093A1 (en) | 1993-08-05 |
NO942757D0 (no) | 1994-07-22 |
ATE175196T1 (de) | 1999-01-15 |
DE69228069T2 (de) | 1999-05-20 |
WO1993015058A1 (en) | 1993-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013379D0 (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
NO994582D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater | |
FI943561A (fi) | Uudet ainekoostumukset | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
DE69228069D1 (de) | 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxochinolin Derivate, als antihypercholesterolemische und antiatherosklerotische Mittel | |
PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
DE69314929D1 (de) | Benzolderivate | |
ES2077697T3 (es) | Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |